loris bertazza
Unit of Endocrinology, Department of Medicine, School of Medicine and Surgery, University of Padua
Padua, Italy
Review Editor
Cancer Endocrinology
Unit of Endocrinology, Department of Medicine, School of Medicine and Surgery, University of Padua
Padua, Italy
Review Editor
Cancer Endocrinology
INSERM U1016 Institut Cochin
Paris, France
Review Editor
Cancer Endocrinology
Sanofi (France)
Paris, France
Review Editor
Cancer Endocrinology
University of Washington
Seattle, United States
Review Editor
Cancer Endocrinology
University of British Columbia
Vancouver, Canada
Review Editor
Cancer Endocrinology
osteoncology and rare tumors center (CDO-TR), IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) “Dino Amadori”
Meldola, Italy
Review Editor
Cancer Endocrinology
Magna Græcia University
Catanzaro, Italy
Review Editor
Cancer Endocrinology
Memorial Sloan Kettering Cancer Center
New York, United States
Review Editor
Cancer Endocrinology
Institut National de la Santé et de la Recherche Médicale (INSERM)
Paris, France
Review Editor
Cancer Endocrinology
Division of Endocrinology, Department of Clinical and Experimental Medicine, University of Pisa
Pisa, Italy
Review Editor
Cancer Endocrinology
Leibniz Institute for Farm Animal Biology (FBN)
Dummerstorf, Germany
Review Editor
Cancer Endocrinology
Indiana University
Bloomington, United States
Review Editor
Cancer Endocrinology
Division of Endocrinology, Department of Medical Sciences, Siena University Hospital
Siena, Italy
Review Editor
Cancer Endocrinology
San Luigi Gonzaga University Hospital
Orbassano, Italy
Review Editor
Cancer Endocrinology
Hudson Institute of Medical Research
Clayton, Australia
Review Editor
Cancer Endocrinology
Ospedale San Pietro Fatebenefratelli
Rome, Italy
Review Editor
Cancer Endocrinology